Comparison of two different daily dosages (2.4 vs. 1.2 g) of oral mesalazine in maintenance of remission in ulcerative colitis patients: 1-year follow-up study.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples